Fujian Medical University Union Hospital

This study is testing a combination of three drugs (zanidatamab, tislelizumab, and chemotherapy) for people with a specific type of advanced bladder cancer (HER2-positive). The main goal is to see if this treatment can shrink the tumor enough so that patients can keep their bladd…

This study is testing a new, non-surgical treatment for male pattern hair loss. It uses tiny particles called exosomes, which are derived from umbilical cord stem cells, delivered into the scalp with a special microneedle device. The goal is to see if this approach is safe and ca…

This study is testing a personalized approach to pre-surgery treatment for locally advanced esophageal cancer. It aims to see if choosing a patient's pre-surgery therapy based on a specific tumor biomarker (called CPS score) can help more patients achieve a complete response, whe…

This study is testing whether a non-invasive magnetic brain stimulation treatment is safe and effective for people with mild to moderate Alzheimer's disease. Researchers will measure changes in memory, thinking, and behavior in 66 participants. They will also use brain scans to e…

This study is testing a new, personalized method for performing prostate biopsies that aims to use fewer needle sticks. Researchers want to see if this 'reduced-core' method can find prostate cancer just as well as the standard method, while causing less pain, bleeding, and risk …

This study aims to find a better way to predict which AML patients will respond well to chemotherapy. Researchers will measure levels of a hormone called leptin in the bone marrow fluid of 86 newly diagnosed patients. The goal is to see if high leptin levels are linked to poorer …